Efficacy and Safety Outcomes with Pembrolizumab (Pembro) Rechallenge for Patients (Pts) with Advanced/Metastatic Urothelial Cancer (UC) Who Responded To First-Course Treatment
No Thumbnail Available
Date
2023
Authors
Koshkin, V. S.
Danchaivijitr, P.
Bae, W. K.
Semenov, A.
Ozyilkan, O.
Su, Y-L.
Arranz Arija, J. A.
Tsujihata, M.
Boegemann, M.
Hendriks, M. P.